Potassium Iodate (KIO3) — Manufacturer & Supplier | Thyroid Stockpile Supply
Golden Hour Pharma is your single-point-of-contact for pharmaceutical-grade Potassium Iodate supply — engineered for national stockpile programmes, emergency preparedness frameworks, and institutional thyroid protection protocols.
Request a QuotationWhat Is Potassium Iodate?
Chemical Identity
Potassium Iodate (KIO3) is an inorganic compound with the molecular formula KIO3. It is a stable, white crystalline powder that serves as a reliable source of iodine in pharmaceutical applications. Unlike Potassium Iodide (KI), KIO3 demonstrates superior chemical stability — particularly in tropical and high-humidity environments — making it the preferred thyroid blocking agent for long-term national stockpile programmes in many regions.
Pharmaceutical Form
Golden Hour Pharma supplies KIO3 in scored tablet form at standard strengths (170 mg and 85 mg), as well as bulk pharmaceutical-grade powder for government and institutional programmes requiring custom formulations. All tablets are manufactured in WHO-GMP certified facilities.
Thyroid Blocking Mechanism
During a nuclear or radiological emergency, radioactive iodine (I-131) can be released into the environment. The thyroid gland readily absorbs iodine — and if radioactive iodine reaches the thyroid, it significantly increases the risk of thyroid cancer and other disorders. KIO3 works by saturating the thyroid with stable iodine before exposure, effectively blocking the uptake of radioactive isotopes. When administered within the recommended window, thyroid blocking can reduce I-131 absorption by over 95%.
Role in National Stockpiles
Numerous countries — particularly across Africa, MENA, and South-East Asia — maintain or are developing national stockpiles of thyroid blocking agents as part of their radiation emergency preparedness frameworks. KIO3 is frequently selected for these programmes due to its extended shelf life and stability under variable storage conditions, as recognised in WHO and IAEA guidance documents.
KIO3 vs KI: Key Differences
| Factor | Potassium Iodate (KIO3) | Potassium Iodide (KI) |
|---|---|---|
| Chemical Stability | High — resistant to oxidation and humidity | Lower — hygroscopic, degrades in heat and humidity |
| Shelf Life (stockpile) | Longer under variable storage | Shorter without climate-controlled storage |
| WHO Position | Accepted thyroid blocking agent | Accepted thyroid blocking agent |
| Tropical Suitability | Preferred in tropical / humid climates | May require additional packaging protection |
| Iodine Content per mg | ~59% iodine by weight | ~76% iodine by weight |
| Dose Equivalence | 170 mg KIO3 = approx. 130 mg KI | 130 mg standard adult dose |
Both KIO3 and KI are effective thyroid blocking agents recognised by the WHO and IAEA for use in radiation emergencies. The primary advantage of Potassium Iodate lies in its superior chemical stability — it does not degrade as readily in high-temperature or high-humidity environments, making it the practical choice for stockpile programmes in tropical and subtropical regions. The WHO has confirmed that both agents are acceptable for thyroid prophylaxis, and the choice between them often comes down to storage infrastructure and programme-specific requirements.
Golden Hour Pharma supplies both KIO3 and KI. View our Potassium Iodide (KI) product page for detailed KI specifications.
Available Specifications
| Grade | Strength | Form | Packaging |
|---|---|---|---|
| Pharmaceutical (WHO-GMP) | 170 mg | Tablets (scored) | Blister packs / HDPE bottles — 10, 14, 30, 100 count |
| Pharmaceutical (WHO-GMP) | 85 mg | Tablets (scored, paediatric dosing) | Blister packs / HDPE bottles — 10, 14, 30, 100 count |
| Pharmaceutical (BP/USP) | Custom strengths | Tablets / Powder | Bulk drums (25 kg) or custom institutional packaging |
Custom strengths, formulations, and packaging configurations are available for institutional and government orders. Contact us to discuss your specific requirements.
Quality & Compliance
WHO-GMP Certified
All KIO3 products are manufactured in WHO-GMP approved facilities meeting international pharmaceutical standards.
Batch Validation
Every production batch undergoes rigorous analytical testing, dissolution studies, and stability validation before release.
Certificate of Analysis
Full Certificates of Analysis (CoA) are provided with every shipment, documenting assay, purity, dissolution, and impurity profiles.
Pharmacopoeial Compliance
Products manufactured to BP, USP, and IP specifications, with regulatory dossiers available for national authority registration.
Procurement Process
Requirement Consultation
Share your programme specifications — volume, strength, packaging, regulatory requirements, and delivery timeline.
Technical Proposal & Documentation
Receive a detailed proposal with product specifications, Certificates of Analysis (CoA), WHO-GMP documentation, and pricing.
Batch Production & Validation
Your order is manufactured under WHO-GMP conditions with full batch validation, stability testing, and quality release.
Delivery & Ongoing Support
Temperature-controlled logistics with complete shipment documentation. Ongoing support for restocking, shelf-life management, and regulatory queries.
Secure Your KIO3 Supply
Whether you are building a national stockpile, replenishing existing reserves, or evaluating KIO3 for your emergency preparedness programme — Golden Hour Pharma is ready to support your requirements with WHO-GMP certified supply, complete documentation, and dedicated procurement support.